Loading...
XETR
AJ91
Market cap58mUSD
May 02, Last price  
10.20EUR
1D
0.99%
1Q
15.25%
Jan 2017
34.74%
IPO
136.11%
Name

DocCheck AG

Chart & Performance

D1W1MN
P/E
22.60
P/S
0.96
EPS
0.45
Div Yield, %
4.90%
Shrs. gr., 5y
0.18%
Rev. gr., 5y
13.51%
Revenues
53m
-12.29%
11,201,61313,595,69114,693,12015,439,82616,317,69715,434,84417,567,23418,293,98617,799,11819,908,52026,819,65525,936,40128,084,25228,341,35032,324,83763,100,41285,921,32360,899,15253,414,689
Net income
2m
-63.89%
668,902943,701664,040601,340609,969761,1651,396,8771,107,3951,087,5421,693,7692,880,7992,664,5412,411,2862,274,8013,139,7569,202,33811,404,5486,290,0742,271,466
CFO
8m
+27.61%
1,845,078791,451382,182945,8651,782,104667,4841,805,4761,483,4981,305,7692,696,4883,607,1892,728,2492,862,5243,817,6811,819,69512,566,55010,922,6765,887,6627,513,266
Dividend
May 30, 20240.5 EUR/sh
Earnings
May 29, 2025

Profile

DocCheck AG offers marketing, customer relationship management, and e-commerce services for the healthcare sector in Europe. The company operates DocCheck portal for exchanging information on the Internet, and online and e-commerce services for healthcare market players. It also develops and implements communication strategies for new and traditional media on healthcare and business-to-business sectors; and promotes healthcare startups through seed funding. DocCheck AG is based in Cologne, Germany.
URL
https://www.doccheck.ag/
IPO date
Nov 04, 2011
Employees
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
53,415
-12.29%
60,899
-29.12%
Cost of revenue
42,006
48,492
Unusual Expense (Income)
NOPBT
11,409
12,407
NOPBT Margin
21.36%
20.37%
Operating Taxes
2,254
3,051
Tax Rate
19.75%
24.59%
NOPAT
9,155
9,356
Net income
2,271
-63.89%
6,290
-44.85%
Dividends
(3,790)
(5,034)
Dividend yield
Proceeds from repurchase of equity
149
(4,903)
BB yield
Debt
Debt current
896
913
Long-term debt
10,809
12,322
Deferred revenue
1
Other long-term liabilities
131
Net debt
(11,480)
(7,754)
Cash flow
Cash from operating activities
7,513
5,888
CAPEX
(1,892)
(6,446)
Cash from investing activities
(2,016)
(4,918)
Cash from financing activities
(4,536)
(5,811)
FCF
10,974
1,926
Balance
Cash
17,518
15,659
Long term investments
5,667
5,331
Excess cash
20,514
17,945
Stockholders' equity
27,715
26,249
Invested Capital
23,372
25,340
ROIC
37.59%
40.19%
ROCE
25.90%
26.58%
EV
Common stock shares outstanding
5,068
5,061
Price
Market cap
EV
EBITDA
16,482
15,258
EV/EBITDA
Interest
127
1,210
Interest/NOPBT
1.11%
9.75%